Cargando…

Current advances of CRISPR-Cas technology in cell therapy

CRISPR-Cas is a versatile genome editing technology that has been broadly applied in both basic research and translation medicine. Ever since its discovery, the bacterial derived endonucleases have been engineered to a collection of robust genome-editing tools for introducing frameshift mutations or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Hou-Yuan, Ji, Rui-Jin, Zhang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120314/ https://www.ncbi.nlm.nih.gov/pubmed/37193354 http://dx.doi.org/10.1016/j.cellin.2022.100067

Ejemplares similares

CRISPR/Cas Technology Revolutionizes Crop Breeding
por: Tang, Qiaoling, et al.
Publicado: (2023)

The application of CRISPR/Cas technologies to Brassica crops: current progress and future perspectives
por: Li, Jun, et al.
Publicado: (2022)

Applications of CRISPR-Cas Technologies to Proteomics
por: Dolgalev, Georgii, et al.
Publicado: (2021)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
por: Ren, Jiangtao, et al.
Publicado: (2017)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
por: Jeong, Song Hee, et al.
Publicado: (2023)

Optimization of CRISPR–Cas system for clinical cancer therapy
por: Meng, Xiang, et al.
Publicado: (2022)

CRISPR/Cas system: An emerging technology in stem cell research
por: Valenti, Maria Teresa, et al.
Publicado: (2019)

The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
por: Wang, Jingyi, et al.
Publicado: (2020)

Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
por: You, Liting, et al.
Publicado: (2019)

Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy
por: Santos, Renato, et al.
Publicado: (2019)

Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
por: Wu, Shao-Shuai, et al.
Publicado: (2020)

CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
por: Ryczek, Natalia, et al.
Publicado: (2021)

CRISPR/Cas9 technology: applications in oocytes and early embryos
por: Zhang, Yi-ran, et al.
Publicado: (2023)

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
por: Zheng, Ruixuan, et al.
Publicado: (2023)

CRISPR-Cas System: The Current and Emerging Translational Landscape
por: Bhokisham, Narendranath, et al.
Publicado: (2023)

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
por: Patsali, Petros, et al.
Publicado: (2019)

Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
por: Huang, Xiaowen, et al.
Publicado: (2023)

Advances and Opportunities of CRISPR/Cas Technology in Bioengineering Non-conventional Yeasts
por: Shan, Lu, et al.
Publicado: (2021)

Advancements in the synergy of isothermal amplification and CRISPR-cas technologies for pathogen detection
por: Mao, Xiaolei, et al.
Publicado: (2023)

CRISPR-Cas Technology In and Out of the Classroom
por: Dahlberg, Lina, et al.
Publicado: (2018)

CRISPR/Cas9 Technology and Its Utility for Crop Improvement
por: Liu, Hua, et al.
Publicado: (2022)

CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives
por: Huang, Tao, et al.
Publicado: (2022)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)

Recent Advances in CRISPR/Cas9 Delivery Strategies
por: Yip, Bon Ham
Publicado: (2020)

CRISPR/Cas Technologies and Their Applications in Escherichia coli
por: Dong, Huina, et al.
Publicado: (2021)

CRISPR/Cas9 Landscape: Current State and Future Perspectives
por: Tyumentseva, Marina, et al.
Publicado: (2023)

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope
por: Karn, Vamika, et al.
Publicado: (2022)

CRISPR/Cas Genome Editing Technologies for Plant Improvement against Biotic and Abiotic Stresses: Advances, Limitations, and Future Perspectives
por: Wang, Yaxin, et al.
Publicado: (2022)

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
por: Kong, Huimin, et al.
Publicado: (2021)

CRISPR-Cas technology a new era in genomic engineering
por: Parsaeimehr, Ali, et al.
Publicado: (2022)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023)

Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system
por: Shi, Tian-Qiong, et al.
Publicado: (2018)

The applications of CRISPR/Cas system in molecular detection
por: Zhou, Li, et al.
Publicado: (2018)

An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
por: Roueinfar, Mina, et al.
Publicado: (2022)

Application of CRISPR/Cas Technology in Spermatogenesis Research and Male Infertility Treatment
por: Wang, Hao-Qi, et al.
Publicado: (2022)

Engineering disease resistant plants through CRISPR-Cas9 technology
por: Tyagi, Swati, et al.
Publicado: (2020)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mu7k2s5813ikfl6gul7ns7gopr